$48.28
0.90% day before yesterday
NYSE, May 30, 10:12 pm CET
ISIN
US1101221083
Symbol
BMY
Sector
Industry

Bristol-Myers Squibb Stock price

$48.28
-1.92 3.82% 1M
-11.66 19.45% 6M
-8.28 14.64% YTD
+8.03 19.95% 1Y
-27.86 36.59% 3Y
-12.01 19.92% 5Y
-18.20 27.38% 10Y
NYSE, Closing price Fri, May 30 2025
+0.43 0.90%
ISIN
US1101221083
Symbol
BMY
Sector
Industry

Key metrics

Market capitalization $98.25b
Enterprise Value $136.18b
P/E (TTM) P/E ratio 18.15
EV/FCF (TTM) EV/FCF 10.41
EV/Sales (TTM) EV/Sales 2.86
P/S ratio (TTM) P/S ratio 2.06
P/B ratio (TTM) P/B ratio 5.65
Dividend yield 5.01%
Last dividend (FY24) $2.42
Revenue growth (TTM) Revenue growth 4.62%
Revenue (TTM) Revenue $47.64b
EBIT (operating result TTM) EBIT $12.92b
Free Cash Flow (TTM) Free Cash Flow $13.09b
Cash position $11.78b
EPS (TTM) EPS $2.66
P/E forward 8.36
P/S forward 2.13
EV/Sales forward 2.95
Short interest 1.82%
Show more

Is Bristol-Myers Squibb a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

Bristol-Myers Squibb Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a Bristol-Myers Squibb forecast:

7x Buy
25%
20x Hold
71%
1x Sell
4%

Analyst Opinions

28 Analysts have issued a Bristol-Myers Squibb forecast:

Buy
25%
Hold
71%
Sell
4%

Financial data from Bristol-Myers Squibb

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
47,636 47,636
5% 5%
100%
- Direct Costs 12,057 12,057
10% 10%
25%
35,579 35,579
3% 3%
75%
- Selling and Administrative Expenses 7,586 7,586
4% 4%
16%
- Research and Development Expense 9,672 9,672
5% 5%
20%
20,261 20,261
3% 3%
43%
- Depreciation and Amortization 7,345 7,345
20% 20%
15%
EBIT (Operating Income) EBIT 12,916 12,916
23% 23%
27%
Net Profit 5,419 5,419
188% 188%
11%

In millions USD.

Don't miss a Thing! We will send you all news about Bristol-Myers Squibb directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bristol-Myers Squibb Stock News

Neutral
Seeking Alpha
4 days ago
Bristol-Myers Squibb Company (NYSE:BMY ) Bernstein 41st Annual Strategic Decisions Conference May 28, 2025 3:30 PM ET Company Participants Chris Boerner - Chief Executive Officer & Chairman Conference Call Participants Courtney Breen - Bernstein Courtney Breen Fantastic. Hi, everyone.
Neutral
Seeking Alpha
4 days ago
Bristol Myers Squibb's much needed correction has brought the stock back to earth, nearer to its 1Y means while triggering the expanded forward dividend yields. Its dividend investment thesis appears safe as well, as observed in the management's recent payout hike and the still rich cash flows despite the ongoing patent cliff impact. This is on top of the raised FY2025 guidance, given the accel...
Neutral
Business Wire
4 days ago
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference.
More Bristol-Myers Squibb News

Company Profile

Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The firm offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.

Head office United States
CEO Christopher Boerner
Employees 34,100
Founded 1933
Website www.bms.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today